Overview

Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether the clinical pathway for acute ischemic stroke(with combination of traditional Chinese medicine and western medicine) is able to improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of Clinical Pathway
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Treatments:
Aspirin
Criteria
Inclusion Criteria:

- Ischemic stroke diagnosed with both criteria of traditional Chinese medicine and
western medicine;

- 18-85 years old;

- Over 6 hours and within 14 days from onset

- 4<=NIHSS <=22;

- Informed consent signed by patient or his/her family ;

Exclusion Criteria:

- Hemorrhagic stroke;

- Cerebral hernia;

- Serious heart, liver, lung, kidney functional failure,malignancy;

- Not cooperative with physician;

- Psychological disorder;

- Already taken part in other clinical drug trial within the past 3 months